Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umberto Campia

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Vascular Medicine (London, England)|June 17, 2020
Vascular effects of cancer treatmentsUmberto Campia
Journal of the American College of Cardiology|June 18, 2025
Arterial Aneurysms in Loeys-Dietz Syndrome: Building Knowledge for Better CareUmberto Campia
Current Treatment Options in Cardiovascular Medicine|May 17, 2016
Exercise and Aerobic Fitness to Reduce Cancer-Related Cardiovascular ToxicityUmberto Campia, Ana Barac
JACC. Cardiooncology|August 16, 2021
Anthracycline Cardiotoxicity: Can CT Move Us Further?Umberto Campia, Anju Nohria
Journal of the American College of Cardiology|August 21, 2024
Frailty in Peripheral Artery Disease Patients Undergoing Revascularization: There Is Strength in Antithrombotic TherapyUmberto Campia, Giovanni Scimeca
Vascular Medicine (London, England)|May 13, 2017
Membership spotlightEmile R Mohler, Umberto Campia
Journal of the American College of Cardiology|May 31, 2008
Flavanol-rich cocoa a promising new dietary intervention to reduce cardiovascular risk in type 2 diabetes?Umberto Campia, Julio A Panza
Vascular Medicine (London, England)|February 13, 2019
An Interview with the SVM PresidentUmberto Campia, Heather L Gornik
British Journal of Pharmacology|September 8, 2011
Human obesity and endothelium-dependent responsivenessUmberto Campia, Manfredi Tesauro, Carmine Cardillo
Current Heart Failure Reports|July 14, 2010
Acute heart failure with low cardiac output: can we develop a short-term inotropic agent that does not increase adverse events?Umberto Campia, Savina Nodari, Mihai Gheorghiade
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Vascular Medicine (London, England)|June 17, 2020
Vascular effects of cancer treatmentsUmberto Campia
Journal of the American College of Cardiology|June 18, 2025
Arterial Aneurysms in Loeys-Dietz Syndrome: Building Knowledge for Better CareUmberto Campia
Current Treatment Options in Cardiovascular Medicine|May 17, 2016
Exercise and Aerobic Fitness to Reduce Cancer-Related Cardiovascular ToxicityUmberto Campia, Ana Barac
JACC. Cardiooncology|August 16, 2021
Anthracycline Cardiotoxicity: Can CT Move Us Further?Umberto Campia, Anju Nohria
Journal of the American College of Cardiology|August 21, 2024
Frailty in Peripheral Artery Disease Patients Undergoing Revascularization: There Is Strength in Antithrombotic TherapyUmberto Campia, Giovanni Scimeca
Vascular Medicine (London, England)|May 13, 2017
Membership spotlightEmile R Mohler, Umberto Campia
Journal of the American College of Cardiology|May 31, 2008
Flavanol-rich cocoa a promising new dietary intervention to reduce cardiovascular risk in type 2 diabetes?Umberto Campia, Julio A Panza
Vascular Medicine (London, England)|February 13, 2019
An Interview with the SVM PresidentUmberto Campia, Heather L Gornik
British Journal of Pharmacology|September 8, 2011
Human obesity and endothelium-dependent responsivenessUmberto Campia, Manfredi Tesauro, Carmine Cardillo
Current Heart Failure Reports|July 14, 2010
Acute heart failure with low cardiac output: can we develop a short-term inotropic agent that does not increase adverse events?Umberto Campia, Savina Nodari, Mihai Gheorghiade
Pageof 10